NeuroRX Dr Duprez SRL
NeuroRX Dr Duprez reported total assets of 191,565 € at the end of the 2025 financial year (annual accounts filed with the NBB on 29 Jun 2026).
The score of NeuroRX Dr Duprez shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +3856 % Total assets +1812 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
NeuroRX Dr Duprez's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 29 Jun 2026
- Year ended 31 Dec 2024filed on 13 Aug 2025
- Year ended 31 Dec 2023filed on 17 Jun 2024
NeuroRX Dr Duprez's financial analysis
- Solvency64.1%sector median: 72.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of NeuroRX Dr Duprez
NeuroRX Dr Duprez's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 1002.035.239
- VAT number
- BE1002035239
- Peppol
- Registered · 0208:1002035239 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 07 Nov 2023
- Registered office
- 1950 Kraainem
- Latest accounts
- 2025 · filed on 29 Jun 2026
- Activity
- Medical specialists activities (NACE 86220)
NeuroRX Dr Duprez (SRL) has been based in Kraainem since 2023, active in: medical specialists activities. For 2025, it reports a net profit of 100,244 € and equity of 122,808 €; its revenue is not published. Its solvency stands at 64.1%, below the median of its sector (72.2%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to NeuroRX Dr Duprez
Companies in the same business, of comparable size and area, outside its group.
- Van Ruyssevelt Ophtalmo Medical specialists activities Woluwe-Saint-Lambert · balance sheet 191,177 €
- Docteur Tessa GOETGHEBUER, pédiatre Medical specialists activities Woluwe-Saint-Pierre · balance sheet 193,382 €
- Cabinet de Chirurgie du Docteur Serge Hauss Medical specialists activities Chaudfontaine · balance sheet 191,546 €
- Verwacht Quentin Medical specialists activities Auderghem · balance sheet 191,359 €
- Soudomedic Medical specialists activities Anderlecht · balance sheet 189,948 €
- ISA Bokoko Medical specialists activities Montigny-le-Tilleul · balance sheet 193,784 €
- Anesthesie Bruggen J. Medical specialists activities Lanaken · balance sheet 191,522 €
- Dokter Laenen Kristel Medical specialists activities Landen · balance sheet 191,641 €
Frequently asked questions about NeuroRX Dr Duprez
What is the revenue of NeuroRX Dr Duprez?
NeuroRX Dr Duprez files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of NeuroRX Dr Duprez?
In Belgium, the VAT number is the company number prefixed with BE: BE1002035239 for NeuroRX Dr Duprez, if the company is VAT-registered. Its company number (CBE) is 1002.035.239.
Where is the registered office of NeuroRX Dr Duprez?
According to the CBE register, the registered office of NeuroRX Dr Duprez is in 1950 Kraainem.
What is the equity of NeuroRX Dr Duprez?
At the close of the 2025 financial year, the equity of NeuroRX Dr Duprez amounts to 122,808 €, a solvency of 64.1% of total assets.
Who manages NeuroRX Dr Duprez?
The register lists 1 active mandates at NeuroRX Dr Duprez. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of NeuroRX Dr Duprez
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →